SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
C5 Acquisition Corporation (CXAC) trades at a trailing P/E of 198.3. Trailing earnings yield is 0.50%.
Criteria proven by this page:
- VALUE (15/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 198.3); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY 0.50%).
- Trailing Earnings Yield 0.50% — below bond yields — investors are paying a premium for expected growth rather than current earnings.
Overall SharesGrow Score: 51/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
15/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
75/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CXAC
Valuation Multiples
P/E (TTM)198.3
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.05
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings Yield0.50%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2021 |
$0.00 |
$0.00 |
$-29.00 |
- |
| 2022 |
$0.05 |
$0.00 |
$1.52M |
- |
